ACM GLOBAL CENTRAL LABORATORY OPERATIONS LIMITEDActive

Company number 06809803Private limited companyIncorporated 2009

Key figures

£882,623+233.2%
Net assets 2025
-26.8%
Average annual change 2020–2025
-10 m-5 m05 m202020212022202320242025

Like most small UK companies, ACM GLOBAL CENTRAL LABORATORY OPERATIONS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 m20 m202020212022202320242025
Filed accounts2020–2025
20212022202320242025
Total assets—————
Total liabilities—————
Net assets / total equity-6,462,080-5,272,272-3,246,944-662,434882,623
Average number of employees125133150161167
Average pay (per year)—————

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the group in the year under review was that of the provision of clinical laboratory services.

As described in the company's latest filed accounts.

Summary: ACM GLOBAL CENTRAL LABORATORY OPERATIONS LIMITED

Company

ACM GLOBAL CENTRAL LABORATORY OPERATIONS LIMITED is a private limited company registered with Companies House under company number 06809803. It was incorporated on 4 Feb 2009. Its status is active. The registered office is in York (YO10). Its nature of business (SIC 2007) is non-trading company (74990).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files group accounts. Net assets were £882,623, up 233.2% on the previous year. The company had an average of 167 employees. Figures are available for 6 financial years (2020–2025).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 11 Feb 2027.